Paragon Capital Management (Kansas)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,158
| Closed | -$204K | – | 57 |
|
|
2023
Q3 | $204K | Buy |
6,158
+589
| +11% | +$20.8K | 0.12% | 50 |
|
|
2023
Q2 | $204K | Sell |
5,569
-222
| -4% | -$8.64K | 0.12% | 51 |
|
|
2023
Q1 | $236K | Buy |
5,791
+557
| +11% | +$24.1K | 0.14% | 47 |
|
|
2022
Q4 | $268K | Buy |
+5,234
| New | +$251K | 0.17% | 43 |
|
|
2022
Q3 | – | Sell |
-3,884
| Closed | -$204K | – | 60 |
|
|
2022
Q2 | $204K | Sell |
3,884
-177
| -4% | -$9.02K | 0.12% | 61 |
|
|
2022
Q1 | $210K | Buy |
4,061
+43
| +1% | +$2.23K | 0.11% | 60 |
|
|
2021
Q4 | $237K | Buy |
+4,018
| New | +$199K | 0.12% | 50 |
|
|
2020
Q2 | – | Sell |
-3,331
| Closed | -$103K | – | 135 |
|
|
2020
Q1 | $103K | Buy |
+3,331
| New | +$114K | 0.07% | 63 |
|
|
2019
Q4 | – | Sell |
-3,331
| Closed | -$114K | – | 60 |
|
|
2019
Q3 | $114K | Sell |
3,331
-1,054
| -24% | -$38.3K | 0.06% | 60 |
|
|
2019
Q2 | $180K | Sell |
4,385
-82
| -2% | -$3.26K | 0.08% | 54 |
|
|
2019
Q1 | $180K | Sell |
4,467
-453
| -9% | -$18.1K | 0.09% | 53 |
|
|
2018
Q4 | $203K | Sell |
4,920
-2,458
| -33% | -$102K | 0.11% | 53 |
|
|
2018
Q3 | $308K | Buy |
7,378
+4,008
| +119% | +$154K | 0.12% | 46 |
|
|
2018
Q2 | $221K | Sell |
3,370
-5,578
| -62% | -$191K | 0.07% | 62 |
|
|
2018
Q1 | $301K | Buy |
8,948
+1,102
| +14% | +$37.9K | 0.11% | 55 |
|
|
2017
Q4 | $269K | Hold |
7,846
| – | – | 0.09% | 57 |
|
|
2017
Q3 | $265K | Buy |
7,846
+1
| +0% | +$32 | 0.09% | 48 |
|
|
2017
Q2 | $250K | Buy |
7,845
+1,002
| +15% | +$31.6K | 0.08% | 55 |
|
|
2017
Q1 | $222K | Sell |
6,843
-253
| -4% | -$7.98K | 0.07% | 59 |
|
|
2016
Q4 | $218K | Buy |
7,096
+396
| +6% | +$12.1K | 0.07% | 60 |
|
|
2016
Q3 | $215K | Sell |
6,700
-1,183
| -15% | -$39.6K | 0.07% | 57 |
|
|
2016
Q2 | $263K | Buy |
+7,883
| New | +$252K | 0.09% | 56 |
|
|
2016
Q1 | – | Sell |
-7,379
| Closed | -$225K | – | 56 |
|
|
2015
Q4 | $225K | Sell |
7,379
-88
| -1% | -$2.77K | 0.09% | 53 |
|
|
2015
Q3 | $222K | Buy |
7,467
+229
| +3% | +$7.34K | 0.09% | 58 |
|
|
2015
Q2 | $230K | Sell |
7,238
-209
| -3% | -$6.81K | 0.08% | 55 |
|
|
2015
Q1 | $245K | Sell |
7,447
-124
| -2% | -$3.94K | 0.09% | 52 |
|
|
2014
Q4 | $223K | Sell |
7,571
-1,717
| -18% | -$49.2K | 0.08% | 58 |
|
|
2014
Q3 | $260K | Buy |
9,288
+745
| +9% | +$20.9K | 0.1% | 54 |
|
|
2014
Q2 | $240K | Sell |
8,543
-583
| -6% | -$16.6K | 0.09% | 58 |
|
|
2014
Q1 | $278K | Buy |
9,126
+17
| +0.2% | +$507 | 0.12% | 57 |
|
|
2013
Q4 | $264K | Sell |
9,109
-1,775
| -16% | -$51.7K | 0.13% | 55 |
|
|
2013
Q3 | $296K | Buy |
10,884
+667
| +7% | +$18.1K | 0.15% | 53 |
|
|
2013
Q2 | $271 | Buy |
+10,217
| New | +$282K | 0.14% | 55 |
|
Other funds holding PFE
Paragon Capital Management (Kansas)'s PFE Position: Q4 2023 in Review
Paragon Capital Management (Kansas) sold out of Pfizer (PFE) in Q4 2023, closing a stake of 6,158 shares — an estimated $204K sold.
Paragon Capital Management (Kansas) first reported a position in PFE in Q2 2013 and held it in 33 quarters. The position peaked at $308K in Q3 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- Paragon Capital Management (Kansas) reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
- Paragon Capital Management (Kansas) sold 6,158 Pfizer shares in Q4 2023, an estimated $204K.
- Paragon Capital Management (Kansas) first reported a position in Pfizer in Q2 2013 and held it in 33 quarters.
- Paragon Capital Management (Kansas)'s Pfizer position peaked at $308K in Q3 2018.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on Paragon Capital Management (Kansas)'s 13F filing for Q4 2023, filed 13 Feb 2024.